Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis

Table 3

Sensitivity analysis of common pneumonia and COVID-19 pneumonia.

Subject	Efficacy index	Effect value	95% CI
Common pneumonia	Flu-like symptoms	WMD = −1.81	−2.17, −1.47
	Sputum	WMD = −1.10	−1.94, −0.52
	Pulmonary rales	WMD = −2.03	−2.87, −1.21
	Pulmonary imaging improvement	WMD = −1.88	−2.45, −1.37
	Curative effect	OR = 3.65	2.69, 5.13
	Healing period	WMD-1.68	−2.80, −0.53
	Adverse reaction	OR = 0.75	0.50, 1.19
COVID1-19 pneumonia	Flu-like symptoms	OR = 3.18	2.18, 4.63
	Sputum	OR = 4.30	0.36, 47.40
	Shortness of breath	OR = 10.62	2.80, 66.79
	Breathlessness	OR = 4.81	0.29.42.01
	Chest tightness	OR = 3.02	0.77, 28.11
	Pulmonary imaging improvement	OR = 1.77	0.95, 3.41
	Curative effect	OR = 2.49	1.58, 4.85
	Healing period	WMD = −2.06	−4.01, 0.01
	Conversion of severe cases	OR = 0.46	0.10, 0.92
All	Adverse reactions	OR = 0.74	0.54, 1.05

The sensitivity analysis results indicated that deleting individual studies would change the combined results of the meta-analysis.